The Front-End Shift: How Pharma Is Reallocating Patient Services Spend

Report

Our March Patient Services Report explores a fundamental shift in life sciences: the reallocation of patient services spend toward purpose-built, front-end patient and HCP engagement. As manufacturers face delayed starts and early discontinuation, leading organizations are prioritizing engagement models that address the human and behavioral drivers of access, affordability, and adherence—before patients fall through the cracks. The front-end shift is here.